Correlation Between HbA1c Levels and Chronic Complications in Patients with Type 2 Diabetes Mellitus at UNS Hospital

Prasasti Probowirasmi, Coana Sukmagautama, Siti Munawaroh

Abstract

Introduction: Diabetes mellitus has been a burden for global health with 422 million patients. Complication in diabetes patients increase the cost of patient care. This research was conducted to determine the correlation between HbA1c levels and chronic complications of type 2 diabetes mellitus in UNS hospital. Furthermore, the HbA1c predictive threshold and the incidence of chronic problems linked to type 2 diabetes mellitus are also explained in this paper.

Methods: This study used a retrospective cross-sectional design based on 133
inpatient medical records from 2022. Data were collected using a purposive sampling method that adjust the inclusion and exclusion criteria. Data analysis using SPSS 23 software with logistic regression.

Results: (1) There is a significant correlation of HbA1c levels and chronic complication of type 2 diabetes mellitus patients in UNS Hospital. (2) HbA1c score of 6.5% or above is best cutoff to use for determining whether type 2 diabetes mellitus was developing chronic problems. (3) The prevalence of the organ with the most involvement in complication is cardiovascular (51,4%).

Conclusion: There is a significant correlation of HbA1c levels and chronic complication of type 2 diabetes mellitus in UNS Hospital with cardiovascular as the organ with the most involvement.

Keywords

Correlation between type 2 diabetes mellitus; HbA1c; Chronic; Complication; Prevalence

Full Text:

PDF

References

  1. Abu Al-Halaweh, A. et al. (2017) ‘Prevalence of type 2 diabetes mellitus complications among palestinians with T2DM’, Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 11(2017), pp. S783–S787. https://doi.org/10.1016/j.dsx.2017.05.017
  2. Bonner, R. et al. (2020) ‘Diabetic Kidney Disease’, Primary Care - Clinics in Office Practice, 47(4), pp. 645–659. https://doi.org/10.1016/j.pop.2020.08.004
  3. Choi, K. H. et al. (2019) ‘HbA1c (Glycated Hemoglobin) Levels and Clinical Outcome Post-Mechanical Thrombectomy in Patients with Large Vessel Occlusion’, Stroke, 50(1), pp. 119–126. https://doi.org/10.1161/STROKEAHA.118.021598
  4. Ciarambino, T. et al. (2022) ‘Influence of Gender in Diabetes Mellitus and Its Complication’, International Journal of Molecular Sciences, 23(16), pp. 1–13. https://doi.org/10.3390/ijms23168850
  5. Gao, Y. et al. (2016) ‘Association between elevated hemoglobin A1c levels and the outcomes of patients with small-artery occlusion: A hospital-based study’, PLoS ONE, 11(8), pp. 1–11. https://doi.org/10.1371/journal.pone.0160223
  6. Gembillo, G. et al. (2021) ‘Kidney disease in diabetic patients: From pathophysiology to pharmacological aspects with a focus on therapeutic inertia’, International Journal of Molecular Sciences, 22(9). https://doi.org/10.3390/ijms22094824
  7. Guo, W. et al. (2019) ‘Increased levels of glycated hemoglobin A1c and iron deficiency anemia: A review’, Medical Science Monitor, 25, pp. 8371–8378. https://doi.org/10.12659/MSM.916719
  8. Himanshu, D., Ali, W. and Wamique, M. (2020) ‘Type 2 diabetes mellitus: pathogenesis and genetic diagnosis’, Journal of Diabetes and Metabolic Disorders, 19(2), pp. 1959–1966. https://doi.org/10.1007/s40200-020-00641-x
  9. Hjalmarsson, C. et al. (2015) ‘The Role of Prestroke Glycemic Control on Severity and Outcome of Acute Ischemic Stroke’, Stroke Research and Treatment, 2014. https://doi.org/10.1155/2014/694569
  10. Huang, J. et al. (2020) ‘Association between type 2 diabetes mellitus, especially recently uncontrolled glycemia, and intracranial plaque characteristics: A high-resolution magnetic resonance imaging study’, Journal of Diabetes Investigation, 11(5), pp. 1278–1284. https://doi.org/10.1111/jdi.13239
  11. IDF (2021) IDF Diabetes Atlas IDF Diabetes Atlas.
  12. Ismail, L., Materwala, H. and Al Kaabi, J. (2021) ‘Association of risk factors with type 2 diabetes: A systematic review’, Computational and Structural Biotechnology Journal, 19, pp. 1759–1785. https://doi.org/10.1016/j.csbj.2021.03.003
  13. Kautzky-Willer, A., Leutner, M. and Harreiter, J. (2023) ‘Sex differences in type 2 diabetes’, Diabetologia, pp. 986–1002. https://doi.org/10.1007/s00125-023-05891-x
  14. Kiziltoprak, H. et al. (2019) ‘Cataract in diabetes mellitus’, World Journal of Diabetes, 10(3), pp. 140–153. https://doi.org/10.4239/wjd.v10.i3.140
  15. Leon, B. M. and Maddox, T. M. (2015) ‘Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research’, World Journal of Diabetes, 6(13), p. 1246. https://doi.org/10.4239/wjd.v6.i13.1246
  16. Ley, S. H. et al. (2018) ‘Chapter 13: Risk Factors for Type 2 Diabetes’, Diabetes in America 3Rd Edition. Available at: https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/diabetes-in-america-3rd-edition#spectrum
  17. Mohr, D. C. et al. (2022) ‘Association of hemoglobin A1c time in range with risk for diabetes complications’, BMJ Open Diabetes Research and Care, 10(4), pp. 1–8. https://doi.org/10.1136/bmjdrc-2021-002738
  18. Nasr, H. et al. (2023) ‘Association between glycated hemoglobin (HbA1c) level and cardiac perfusion and function on gated myocardial perfusion SPECT’, Egyptian Journal of Radiology and Nuclear Medicine, 54(1). https://doi.org/10.1186/s43055-023-01036-7
  19. Ong, C. (2022) ‘Characteristic of Chronic Complications in Type 2 Diabetic Patient Based on Asian Perspective’, Current Internal Medicine Research and Practice Surabaya Journal, 3(1), p. 13. https://doi.org/10.20473/cimrj.v3i1.31412
  20. PERKENI (2021) ‘Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021’, Global Initiative for Asthma, p. 46. Available at: www.ginasthma.org.
  21. Petrie, J. R., Guzik, T. J. and Touyz, R. M. (2018) ‘Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms’, Canadian Journal of Cardiology, 34(5), pp. 575–584. https://doi.org/10.1016/j.cjca.2017.12.005
  22. Rahmi, A. S., Syafrita, Y. and Susanti, R. (2022) ‘HUBUNGAN LAMA MENDERITA DM TIPE 2 DENGAN KEJADIAN NEUROPATI DIABETIK’, 003.
  23. De Rosa, S. et al. (2018) ‘Type 2 diabetes mellitus and cardiovascular disease: Genetic and epigenetic links’, Frontiers in Endocrinology, 9(JAN), pp. 1–13. https://doi.org/10.3389/fendo.2018.00002
  24. Sherwani, S. I. et al. (2016) ‘Significance of HbA1c test in diagnosis and prognosis of diabetic patients’, Biomarker Insights, 11, pp. 95–104. https://doi.org/10.4137/Bmi.s38440
  25. Škrha, J. et al. (2016) ‘Glucose variability, HbA1c and microvascular complications’, Reviews in Endocrine and Metabolic Disorders, 17(1), pp. 103–110. https://doi.org/10.1007/s11154-016-9347-2
  26. Suharni, S., Zulkarnaini, A. and Kusnadi, D. T. (2021) ‘Kadar HbA1C Pada Pasien Diabetes Melitus Tipe 2 dengan Komplikasi Neuropati Diabetik di RSI Siti Rahmah Padang Tahun 2019-2020’, Baiturrahmah Medical Journal, 1(2), pp. 32–36. Available at: https://jurnal.unbrah.ac.id/index.php/brmj/article/view/1027
  27. Sumardiyono, B. and Suri, I. K. (2022) ‘Neuropati Diabetika Kontribusi Karakteristik Individu, Lama Sakit, Merokok.’, Jurnal Kesehatan Masyarakat Indonesia, 17(2), pp. 1–5. Available at: https://jurnal.unimus.ac.id/index.php/jkmi
  28. Wang, B. et al. (2016) ‘Cutoff point of hba1c for diagnosis of diabetes mellitus in Chinese individuals’, PLoS ONE, 11(11), pp. 1–9. https://doi.org/10.1371/journal.pone.0166597
  29. Wu, T. E., Su, Y. W. and Chen, H. S. (2022) ‘Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus’, Diabetes Research and Clinical Practice, 192, p. 110069. https://doi.org/10.1016/j.diabres.2022.110069
  30. Zhaolan L., Chaowei F., W. W. and X., B. (2018) ‘Prevalencia de complicaciones crónicas de la diabetes mellitus tipo 2 en pacientes ambulatorios: una encuesta transversal basada en el hospital en la China urbana’, Health and Quality of Life Outcomes, 8. Available at: http://www.hqlo.com/content/8/1/62

DOI: https://doi.org/10.13057/smj.v8i1.94924

Refbacks

  • There are currently no refbacks.